An Ozempic alternative shows promising weight loss results — and Novo Nordisk stock surges 12%

Balazs Barabas

In This Story NVO +8.08% LLY +1.69% Novo Nordisk ( NVO +8.08% ) stock jumped 12% in pre-market trading Friday after it released promising results of an early-stage weight loss drug trial. Suggested Reading Tesla's Model Y refresh is now for sale in the U.S. OpenAI's new Operator AI agent handles tasks — but with hiccups Apple Intelligence now turns on automatically. Here's how you can turn it off How Nike’s new CEO plans to revive the struggling sportswear giant Share Share this Video Facebook

Tag-uri: Facebook